Especially since they now get 5.5 million ngio shares (was 3.5 mil) and price protection on their 8.4 mil Gnbt shares. That downside protection is null and void if any new materially negative info not disclosed during dd between the companies emerges. For this to work things really need to progress positively on the Veneto side.
It’s great there’s no dilutive effect on the Gnbt side. Good on Joe, as usual. It’s Kevin from Veneto that needs to show his worth, in my opinion.
(1)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links